Citation & Authors
Mol Cancer. 2026;25(1):89.
ABSTRACT · RESEARCH SUMMARY
Research summary
Combining human tissue, cellular, three-dimensional culture, and mouse models, the study found that ANT2 was upregulated in metastatic breast cancer and formed an energy-metabolism complex with ATP5B. Inhibiting ANT2 reduced ATP production, invasion, and metastasis; cymarin also showed preclinical inhibitory activity. These findings support a potential therapeutic target, not established efficacy in patients or a medication recommendation.
Key points based on the public abstract; this is a reading guide, not a full abstract translation.Read original abstract ↗
